| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Novavax Inc (NASDAQ: NVAX)
NVAX Technical Analysis
5
| As on 9th Jun 2023 NVAX SHARE Price closed @ 7.47 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 60.29 & Strong Sell for SHORT-TERM with Stoploss of 110.41 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NVAXSHARE Price
| Open | 7.74 | Change | Price | % |
| High | 8.20 | 1 Day | -0.22 | -2.86 |
| Low | 7.45 | 1 Week | 0.26 | 3.61 |
| Close | 7.47 | 1 Month | -0.16 | -2.10 |
| Volume | 5504364 | 1 Year | -209.85 | -96.56 |
| 52 Week High 217.32 | 52 Week Low 5.76 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| NVAX Daily Charts |
NVAX Intraday Charts |
Whats New @ Bazaartrend |
NVAX Free Analysis |
|
|
NVAX Important Levels Intraday
| RESISTANCE | 8.92 |
| RESISTANCE | 8.45 |
| RESISTANCE | 8.17 |
| RESISTANCE | 7.88 |
| SUPPORT | 7.06 |
| SUPPORT | 6.77 |
| SUPPORT | 6.49 |
| SUPPORT | 6.02 |
NVAX Forecast April 2024
| 4th UP Forecast | 148.56 |
| 3rd UP Forecast | 103.31 |
| 2nd UP Forecast | 75.34 |
| 1st UP Forecast | 47.37 |
| 1st DOWN Forecast | -32.43 |
| 2nd DOWN Forecast | -60.4 |
| 3rd DOWN Forecast | -88.37 |
| 4th DOWN Forecast | -133.62 |
NVAX Weekly Forecast
| 4th UP Forecast | 107.06 |
| 3rd UP Forecast | 75.12 |
| 2nd UP Forecast | 55.38 |
| 1st UP Forecast | 35.64 |
| 1st DOWN Forecast | -20.70 |
| 2nd DOWN Forecast | -40.44 |
| 3rd DOWN Forecast | -60.18 |
| 4th DOWN Forecast | -92.12 |
NVAX Forecast2024
| 4th UP Forecast | 452.4 |
| 3rd UP Forecast | 309.71 |
| 2nd UP Forecast | 221.51 |
| 1st UP Forecast | 133.31 |
| 1st DOWN Forecast | -118.37 |
| 2nd DOWN Forecast | -206.57 |
| 3rd DOWN Forecast | -294.77 |
| 4th DOWN Forecast | -437.46 |
Novavax Inc ( NASDAQ USA Symbol : NVAX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NVAX Business Profile
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. In addition, the company develops vaccine candidates for the protection against middle east respiratory syndrome, as well as that is in preclinical work associated with severe acute respiratory syndrome; and ebola virus glycoprotein vaccine candidate, as well as COVID-19 vaccine for variant strain. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland. Address: 21 Firstfield Road, Gaithersburg, MD, United States, 20878
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service